Drugs / PM02734
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00884845 | Jan 2009 → Jun 2011 | cancer | PharmaMar | Completed | No outcome recorded |
| Phase 1 | NCT00404521 | Aug 2005 → May 2011 | cancer | PharmaMar | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PM02734 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00884845 ↗ |
| Route | Intravenous | “Administered every 3 weeks, intravenously, over 30 minutes” NCT00404521 ↗ |